Neogen Corporation (NEOG) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Medical - Diagnostics & Research
EV/EBITDA
↓
20.79
↓-31% vs avg
5yr avg: 30.13
30Y Low10.2·High51.1
P/FCF
↓
N/A
—
5yr avg: 78.23
30Y Low9.4·High139.1
P/B Ratio
↓
0.97
↓-58% vs avg
5yr avg: 2.34
30Y Low0.6·High7.1
ROE
↓
-41.9%
↑-599% vs avg
5yr avg: -6.0%
30Y Low-42%·High13%
Debt/EBITDA
↑
6.76
↑+46% vs avg
5yr avg: 4.62
30Y Low0.0·High7.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
NEOG Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Neogen Corporation currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.0B | $1.3B | $2.8B | $3.3B | $2.9B | $4.9B | $3.8B | $3.0B | $4.0B | $2.4B | $1.9B |
| Enterprise Value | $2.8B | $2.1B | $3.6B | $4.0B | $2.8B | $4.9B | $3.7B | $2.9B | $3.9B | $2.4B | $1.8B |
| P/E Ratio → | -1.85 | — | — | — | 58.80 | 80.96 | 63.59 | 49.42 | 63.08 | 55.21 | 51.44 |
| P/S Ratio | 2.26 | 1.42 | 3.08 | 4.02 | 5.42 | 10.55 | 9.00 | 7.13 | 9.93 | 6.72 | 5.82 |
| P/B Ratio | 0.97 | 0.61 | 0.91 | 1.05 | 3.22 | 5.88 | 5.19 | 4.63 | 7.05 | 5.15 | 4.63 |
| P/FCF | — | — | — | — | 65.54 | 90.91 | 60.89 | 60.06 | 81.99 | 53.16 | 88.61 |
| P/OCF | 34.77 | 21.82 | 80.73 | 80.52 | 42.01 | 60.96 | 43.84 | 46.26 | 57.14 | 40.30 | 52.94 |
P/E links to full P/E history page with 30-year chart
NEOG EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Neogen Corporation's enterprise value stands at 20.8x EBITDA, 31% below its 5-year average of 30.1x. The Healthcare sector median is 14.2x, placing the stock at a 46% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.30 | 3.88 | 4.91 | 5.34 | 10.39 | 8.85 | 7.03 | 9.72 | 6.50 | 5.65 |
| EV / EBITDA | 20.79 | 15.21 | 18.03 | 32.07 | 34.18 | 51.14 | 43.06 | 33.97 | 44.32 | 29.53 | 26.47 |
| EV / EBIT | 298.17 | — | 58.37 | 119.04 | 46.73 | 64.69 | 51.16 | 39.91 | 52.64 | 35.27 | 32.70 |
| EV / FCF | — | — | — | — | 64.52 | 89.55 | 59.84 | 59.21 | 80.26 | 51.47 | 85.99 |
NEOG Profitability
Margins and return-on-capital ratios measuring operating efficiency
Neogen Corporation earns an operating margin of 1.1%. Operating margins have compressed from 4.6% to 1.1% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -41.9% indicates the company is currently destroying shareholder equity. ROIC of 0.2% represents below-average returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 47.1% | 47.1% | 50.1% | 49.4% | 46.1% | 45.9% | 46.9% | 46.3% | 46.8% | 47.6% | 47.6% |
| Operating Margin | 1.1% | 1.1% | 8.4% | 4.6% | 11.1% | 15.8% | 16.1% | 16.4% | 17.6% | 18.0% | 17.6% |
| Net Profit Margin | -122.1% | -122.1% | -1.0% | -2.8% | 9.2% | 13.0% | 14.2% | 14.5% | 15.9% | 12.1% | 11.4% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -41.9% | -41.9% | -0.3% | -1.1% | 5.6% | 7.8% | 8.7% | 10.0% | 12.2% | 10.0% | 9.7% |
| ROA | -27.3% | -27.3% | -0.2% | -0.8% | 5.1% | 7.1% | 8.0% | 9.2% | 11.0% | 8.9% | 8.7% |
| ROIC | 0.2% | 0.2% | 1.5% | 1.2% | 5.5% | 7.8% | 8.1% | 9.5% | 12.1% | 13.1% | 13.3% |
| ROCE | 0.2% | 0.2% | 1.8% | 1.4% | 6.6% | 9.2% | 9.6% | 11.0% | 13.1% | 14.2% | 14.3% |
NEOG Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Neogen Corporation carries a Debt/EBITDA ratio of 6.8x, which is highly leveraged (110% above the sector average of 3.2x). Net debt stands at $784M ($913M total debt minus $129M cash). Interest coverage of just 0.1x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.44 | 0.44 | 0.29 | 0.29 | — | 0.00 | 0.00 | — | — | — | — |
| Debt / EBITDA | 6.76 | 6.76 | 4.56 | 7.13 | — | 0.01 | 0.01 | — | — | — | — |
| Net Debt / Equity | — | 0.38 | 0.23 | 0.23 | -0.05 | -0.09 | -0.09 | -0.07 | -0.15 | -0.16 | -0.14 |
| Net Debt / EBITDA | 5.80 | 5.80 | 3.70 | 5.83 | -0.54 | -0.78 | -0.76 | -0.49 | -0.95 | -0.97 | -0.81 |
| Debt / FCF | — | — | — | — | -1.02 | -1.37 | -1.05 | -0.85 | -1.72 | -1.70 | -2.62 |
| Interest Coverage | 0.13 | 0.13 | 1.05 | 0.67 | 814.14 | 950.88 | — | — | — | — | — |
NEOG Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Neogen Corporation's current ratio of 3.32x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.22x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 4.03x to 3.32x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.32 | 3.32 | 3.82 | 4.03 | 8.05 | 11.03 | 11.08 | 11.75 | 9.71 | 8.14 | 8.74 |
| Quick Ratio | 2.22 | 2.22 | 2.59 | 3.11 | 6.48 | 9.16 | 9.12 | 9.50 | 7.75 | 6.11 | 6.49 |
| Cash Ratio | 0.74 | 0.74 | 1.11 | 1.69 | 4.90 | 7.11 | 7.09 | 6.99 | 5.45 | 3.99 | 3.77 |
| Asset Turnover | — | 0.26 | 0.20 | 0.18 | 0.53 | 0.51 | 0.52 | 0.60 | 0.64 | 0.68 | 0.71 |
| Inventory Turnover | 2.48 | 2.48 | 2.44 | 3.11 | 2.32 | 2.52 | 2.33 | 2.58 | 2.78 | 2.59 | 2.61 |
| Days Sales Outstanding | — | 62.58 | 68.32 | 68.01 | 69.01 | 71.54 | 73.91 | 72.78 | 72.54 | 69.22 | 76.86 |
NEOG Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Neogen Corporation does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 1.7% | 1.2% | 1.6% | 2.0% | 1.6% | 1.8% | 1.9% |
| FCF Yield | — | — | — | — | 1.5% | 1.1% | 1.6% | 1.7% | 1.2% | 1.9% | 1.1% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $217M | $216M | $189M | $108M | $107M | $106M | $105M | $104M | $102M | $101M |
Peer Comparison
Compare NEOG with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 NEOGYou | $2B | -1.9 | 20.8 | — | 47.1% | 1.1% | -41.9% | 0.2% | 6.8 |
 IDXX | $45B | 43.0 | 31.1 | 42.4 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 |
 BCAL | $635M | 10.2 | 7.4 | 11.1 | 79.4% | 37.8% | 11.6% | 10.6% | 0.8 |
 QDEL | $931M | -0.8 | — | — | 46.7% | -33.7% | -46.1% | -13.6% | — |
 NVAX | $2B | 3.6 | 2.6 | — | 93.7% | 50.1% | — | — | 0.4 |
 BIO | $8B | 10.1 | 18.1 | 20.4 | 52.0% | 10.5% | 10.8% | 2.6% | 3.2 |
 MESO | $2B | -17.1 | — | — | 70.2% | -363.1% | -19.0% | -8.5% | — |
 FELE | $5B | 32.1 | 14.4 | 23.8 | 35.5% | 12.7% | 11.3% | 14.7% | 0.8 |
 PRAX | $8B | -20.9 | — | — | — | — | -45.8% | -65.0% | — |
 TSN | $20B | 40.8 | 9.8 | 16.8 | 6.5% | 2.6% | 2.6% | 4.1% | 3.2 |
 CAG | $6B | 5.5 | 8.3 | 4.8 | 25.9% | 11.8% | 12.9% | 6.0% | 4.7 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
NEOG — Frequently Asked Questions
Quick answers to the most common questions about buying NEOG stock.
What is Neogen Corporation's P/E ratio?
Neogen Corporation's current P/E ratio is -1.9x. The historical average is 38.9x.
What is Neogen Corporation's EV/EBITDA?
Neogen Corporation's current EV/EBITDA is 20.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 23.9x.
What is Neogen Corporation's ROE?
Neogen Corporation's return on equity (ROE) is -41.9%. The historical average is 7.9%.
Is NEOG stock overvalued?
Based on historical data, Neogen Corporation is trading at a P/E of -1.9x. Compare with industry peers and growth rates for a complete picture.
What are Neogen Corporation's profit margins?
Neogen Corporation has 47.1% gross margin and 1.1% operating margin.
How much debt does Neogen Corporation have?
Neogen Corporation's Debt/EBITDA ratio is 6.8x, indicating high leverage. A ratio above 4x may signal elevated financial risk.